Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse

NCT01945580 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01945580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01945580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 10, 2014
Completion date
February 12, 2020
Enrollment
374 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse